| Literature DB >> 30100984 |
Madhurendra Singh1,2, Laura Bergmann1, Alexander Lang1, Katja Pexa1, Fabian Kuck1, Dennis Stibane1, Linda Janke3, Hakima Ezzahoini1, Antje Lindecke4, Constanze Wiek5, Helmut Hanenberg5,6, Karl Köhrer4, Charlotte von Gall7, Hans Reinke3,8, Roland P Piekorz1.
Abstract
The albumin D-box binding protein (DBP) is a member of the PAR bZip (proline and acidic amino acid-rich basic leucine zipper) transcription factor family and functions as important regulator of circadian core and output gene expression. Gene expression of DBP itself is under the control of E-box-dependent binding by the Bmal1-Clock heterodimer and CRE-dependent binding by the cAMP responsive element binding protein (CREB). However, the signaling mechanism mediating CREB-dependent regulation of DBP expression in the peripheral clock remains elusive. In this study, we examined the role of the GPCR (G-protein-coupled receptor)/Gαi3 (Galphai3) controlled cAMP-CREB signaling pathway in the regulation of hepatic expression of core clock and clock-regulated genes, including Dbp. Analysis of circadian gene expression revealed that rhythmicity of hepatic transcript levels of the majority of core clock (including Per1) and clock-regulated genes were not affected by Gαi3 deficiency. Consistently, the period length of primary Gαi3 deficient tail fibroblasts expressing a Bmal1-Luciferase reporter was not affected. Interestingly, however, Gαi3 deficient female but not male mice showed a tendentiously increased activation of CREB (nuclear pSer133-CREB) accompanied by an advanced peak in Dbp gene expression and elevated mRNA levels of the cytochrome P450 family member Cyp3a11, a target gene of DBP. Accordingly, selective inhibition of CREB led to a strongly decreased expression of DBP and CYP3A4 (human Cyp3a11 homologue) in HepG2 liver cells. In summary, our data suggest that the Gαi3-pCREB signalling pathway functions as a regulator of sexual-dimorphic expression of DBP and its xenobiotic target enzymes Cyp3a11/CYP3A4.Entities:
Keywords: CREB; Pathology; albumin D-box binding protein; circadian regulation; cytochrome P450; galphai3/GNAI3
Year: 2018 PMID: 30100984 PMCID: PMC6084400 DOI: 10.18632/oncotarget.25727
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Figure 1Rhythmic expression of core clock genes and clock-regulated genes in the liver of Gα-/- mice
Quantitative real-time PCR analysis of rhythmic expression of core clock genes and clock output genes in the liver of female (A) and male (B) Gαi3 deficient mice vs. wild-type control animals. Mice were sacrificed and analyzed every six hours at the indicated time points (ZT 0 to ZT 18). Transcript levels of the indicated genes were normalized to the endogenous control Gapdh. Shown are 2-ΔCt values. Results are expressed as mean ± s.d. of six animals analyzed per genotype and time point (*p < 0.05; **p < 0.01 as compared to corresponding wild-type control animals).
Figure 2Rhythmic expression of DBP in the liver of female Gαi3-/- mice is phase advanced (A, B) Quantitative real-time PCR analysis of rhythmic expression of DBP mRNA in the liver of female (A) and male (B) Gαi3 deficient mice as compared to wild-type control animals. Dbp transcript levels were normalized to the endogenous control Gapdh. Shown are 2-ΔCt values. (C, D) Representative immunoblots of rhythmic expression of the DBP protein in the liver of female (C) and male (D) Gαi3-deficient mice and wild-type controls. GAPDH and β-Actin were employed as loading controls. Relative protein levels (DBP/GAPDH) were determined by densitometric analysis using ImageJ software (lower panels in C and D). Mice were sacrificed and analyzed every six hours at the indicated time points (ZT 0 to ZT 18). Results are expressed as mean ± s.d. of six animals (mRNA) or four animals (immunoblot) analyzed per genotype and time point (*p < 0.05; **p < 0.01 as compared to corresponding wild-type control animals).
Figure 3Gαi3-/- female mice display increased nuclear pSer133-CREB levels in the liver
(A) Immunoblot analysis of pSer133-CREB and CREB protein levels in nuclear extracts from livers of female wild-type vs. Gα-/- mice. (B) Quantitative analysis of relative protein levels (pSer133-CREB/CREB) was performed by ImageJ software. Results are expressed as mean ± s.d. of three independent experiments. Mice were sacrificed and analyzed every six hours at the indicated time points (ZT 0 to ZT 18). ATF1, activating transcription factor 1.
Figure 4Transcript levels of the DBP target gene and cytochrome P450 family member Cyp3a11 are increased in the liver of Gα-/- female mice
Quantitative real-time PCR analysis of rhythmic expression of Cyp3a11 and Cyp2a4/a5 genes in the liver of female (A) and male (B) Gαi3 deficient mice vs. wild-type control animals. Mice were sacrificed and analyzed every six hours at the indicated time points (ZT 0 to ZT 18). Transcript levels of Cyp3a11 and Cyp2a4/a5 were normalized to the endogenous control Gapdh. Shown are 2-ΔCt values. Results are expressed as mean ± s.d. of five animals analyzed per genotype and time point (*p < 0.05; **p < 0.01 as compared to corresponding wild-type control animals).
Figure 5Schematic model suggesting a putative role of the Gas/Gαi3-CREB signalling pathways in sexually-dimorphic regulation of DBP expression in female vs. male mouse liver
In females, loss of Gαi3 leads presumably via desinhibition of adenylyl cyclase and hence increased pSer133-CREB levels to a phase-advanced and increased expression of DBP in the liver, concomitant with an increase in transcript levels of Cyp3a11, a putative DBP target gene. In Gα-/- males, this signalling pathway may be less active provided that an increased CRY1 expression (as indicated in Figure 1) results in a stronger inhibitory role of CRY1 on cAMP levels (via Gs inhibition) [24]. B: BMAL1; C: CLOCK; CRE: cAMP responsive element; CREB, cAMP response element binding protein; CRY1, cryptochrome circadian clock 1; Cyp3a11: cytochrome P450, family 3, subfamily a, polypeptide 11; DBP: albumin D-box binding protein; PKA: protein kinase A; Gi3 and Gs: heterotrimeric guanine nucleotide binding proteins which upon activation cause a decrease or increase in intracellular cAMP levels, respectively.